About 6.8 million doses of J & J vaccines have been administered to individuals of U.S. But recently 6 cases were presented with Adverse Drug Reaction.
The 6 cases were examined together by CDC and FDA. There were rare yet severe type of blood clots that occurred to the individuals receiving J & J’s Vaccine. This type of Blood clot is known as Cerebral Venous Sinus Thrombosis (CVST).
All the six cases were reported on women within the age group of 18 to 48 and symptoms started to appear after 6 – 13 days of administration of the vaccine.
Generally, an anticoagulant drug known as Heparin is used to treat the normal blood clots but in this case heparin might worsen the situation and hence different treatment approach should be applied.
Along with Advisory Committee on Immunization Practices (ACIP) , CDC has decided to conduct a meeting on Wednesday to discuss over the Adverse effects of this J & J’s Vaccine. FDA will further analyze these Adverse reactions and the cases. Till that CDC and FDA have decided to pause the administration of J & J’s Vaccine.
This is critical in unit to prevent that the health-care system is mindful of the risk of these adverse effects and can prepare for adequate identification and management as a result of the particular medication needed for this form of blood clot.
The authorities also stated that these adverse effects were rare. Also, the safety of the COVID 19 vaccine is their top Priority and officials are taking care of each and ever Adverse events and the health issues associated with the vaccines.
Moreover, it is advised for the individuals who received J & J’s vaccine to contact the health care workers if the undergo symptoms like headache, abdominal pain, leg pain, or shortness of breath within three weeks of vaccine administration. Also, health care workers are advised to report the ADRs accordingly.